Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy

NCT00002488 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: etoposide

Sponsor

Ottawa Regional Cancer Centre